EVRA (Early Venous Reflux Ablation) Ulcer Trial presented for the first time at the Charing Cross Symposium Alun Davies, EVRA chief investigator Imperial College, London, United Kingdom cxsymposium2019-09-09T09:23:21+01:00 Share This Story, Choose Your Platform! FacebookXRedditLinkedInTumblrPinterestVkEmail Related Posts CX 2025: Aortic Challenges Programme Highlights March 4th, 2025 | 0 Comments CX 2025: Early Bird deadline ending soon! February 21st, 2025 | 0 Comments CX 2025: Aortic Programme Highlights February 14th, 2025 | 0 Comments CX 2025: Venous & Lymphatic Programme Highlights February 7th, 2025 | 0 Comments Charing Cross: A “Must-Attend” for Vascular Specialists February 5th, 2025 | 0 Comments